Title: | COVID-19 is an emergent disease of aging |
Journal: | Aging Cell |
Published: | 1 Oct 2020 |
Pubmed: | https://pubmed.ncbi.nlm.nih.gov/33006233/ |
DOI: | https://doi.org/10.1111/acel.13230 |
Citations: | 130 (35 in last 2 years) as of 8 Aug 2024 |
Title: | COVID-19 is an emergent disease of aging |
Journal: | Aging Cell |
Published: | 1 Oct 2020 |
Pubmed: | https://pubmed.ncbi.nlm.nih.gov/33006233/ |
DOI: | https://doi.org/10.1111/acel.13230 |
Citations: | 130 (35 in last 2 years) as of 8 Aug 2024 |
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
COVID-19 is an ongoing pandemic caused by the SARS-CoV-2 coronavirus that poses one of the greatest challenges to public health in recent years. SARS-CoV-2 is known to preferentially target older subjects and those with pre-existing conditions, but the reason for this age dependence is unclear. Here, we found that the case fatality rate for COVID-19 grows exponentially with age in all countries tested, with the doubling time approaching that of all-cause human mortality. In addition, men and those with multiple age-related diseases are characterized by increased mortality. Moreover, similar mortality patterns were found for all-cause pneumonia. We further report that the gene expression of ACE2, the SARS-CoV-2 receptor, grows in the lung with age, except for subjects on a ventilator. Together, our findings establish COVID-19 as an emergent disease of aging, and age and age-related diseases as its major risk factors. In turn, this suggests that COVID-19, and deadly respiratory diseases in general, may be targeted, in addition to antiviral approaches, by approaches that target the aging process.</p>
Enabling scientific discoveries that improve human health